Studies in chronic kidney disease (CKD) patients have shown that elevated FGF23 levels are independently associated with CKD progression, left ventricular (LV) hypertrophy, cardiovascular risk, and all-cause mortality [8,9,10]. This evidence concerns the gene FGF23 and chronic kidney disease.